EUSA Pharma, a transatlantic specialty pharmaceutical company focused on oncology, oncology supportive care and critical care, today announced that the US Food and Drug Administration (FDA) has approved its orphan drug ERWINAZE™ (asparaginase Erwinia ... FDA approves EUSA's orphan drug ERWINAZE for acute lymphoblastic leukemia
Friday, November 18, 2011
FDA approves EUSA's orphan drug ERWINAZE for acute lymphoblastic leukemia
EUSA Pharma, a transatlantic specialty pharmaceutical company focused on oncology, oncology supportive care and critical care, today announced that the US Food and Drug Administration (FDA) has approved its orphan drug ERWINAZE™ (asparaginase Erwinia ... FDA approves EUSA's orphan drug ERWINAZE for acute lymphoblastic leukemia
Subscribe to:
Post Comments (Atom)
Popular Posts
-
Was würde besser zum Thema "Schöne Heimat" passen als qualitativ hochwertige Produkte aus dem Salzburger Land. Und deshalb könnt ...
-
Entertainment News from AP Entertainment News from AP AP National News Video More>> AP News Minute: US students arrested in Egypt BOG...
No comments:
Post a Comment